146 filings
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
10-Q
2024 Q1
VIR
Vir Biotechnology Inc
Quarterly report
3 May 24
4:16pm
8-K
VIR
Vir Biotechnology Inc
2 May 24
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:09pm
ARS
2023 FY
VIR
Vir Biotechnology Inc
19 Apr 24
Annual report to shareholders
8:40am
DEFA14A
VIR
Vir Biotechnology Inc
19 Apr 24
Additional proxy soliciting materials
8:35am
8-K
dygtt
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
S-8
vozs0c1qtej0tw4x
26 Feb 24
Registration of securities for employees
4:27pm
8-K
su736ijcb7414
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
8-K
9s9ahnr4s6jfu0spfdc
20 Feb 24
Departure of Directors or Certain Officers
4:33pm
8-K
yt3t v8b1xxmtr
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
8-K
w8krt 04ot22t5a6
3 Nov 23
Entry into a Material Definitive Agreement
4:37pm
S-3ASR
stso4syii
3 Nov 23
Automatic shelf registration
4:33pm
8-K
vam7mllccm6tgt0ed
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
guq0ntzx
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
8-K
jdsvxjxmd69epnxl6
20 Sep 23
Departure of Directors or Certain Officers
6:02am
8-K
ih3ww8rpriaoi9vz1y7o
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm